Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
British journal of cancer | 2022-11-01 | PMID 36207609
Jacot William, Lusque Amélie, Vicier Cécile and 14 more
